Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov 1;61(3):302-9.
doi: 10.1097/QAI.0b013e31826a6c4f.

Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals

Lesley A Inker  1 , Christina Wyatt, Rebecca Creamer, James Hellinger, Matthew Hotta, Maia Leppo, Andrew S Levey, Aghogho Okparavero, Hiba Graham, Karen Savage, Christopher H Schmid, Hocine Tighiouart, Fran Wallach, Zipporah Krishnasami
Affiliations

Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals

Lesley A Inker et al. J Acquir Immune Defic Syndr. .

Abstract

Objective: To evaluate the performance of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) creatinine, cystatin C, and creatinine-cystatin C estimating equations in HIV-positive patients.

Methods: We evaluated the performance of the Modification of Diet in Renal Disease (MDRD) Study and CKD-EPI creatinine 2009, CKD-EPI cystatin C 2012, and CKD-EPI creatinine-cystatin C 2012 glomerular filtration rate (GFR) estimating equations compared with GFR measured using plasma clearance of iohexol in 200 HIV-positive patients on stable antiretroviral therapy. Creatinine and cystatin C assays were standardized to certified reference materials.

Results: Of the 200 participants, median (IQR) CD4 count was 536 (421) and 61% had an undetectable HIV viral load. Mean (SD) measured GFR (mGFR) was 87 (26) mL/min per 1.73 m. All CKD-EPI equations performed better than the MDRD Study equation. All 3 CKD-EPI equations had similar bias and precision. The cystatin C equation was not more accurate than the creatinine equation. The creatinine-cystatin C equation was significantly more accurate than the cystatin C equation, and there was a trend toward greater accuracy than the creatinine equation. Accuracy was equal or better in most subgroups with the combined equation compared to either alone.

Conclusions: The CKD-EPI cystatin C equation does not seem to be more accurate than the CKD-EPI creatinine equation in patients who are HIV-positive, supporting the use of the CKD-EPI creatinine equation for routine clinical care for use in North American populations with HIV. The use of both filtration markers together as a confirmatory test for decreased estimated GFR based on creatinine in individuals who are HIV-positive requires further study.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest:

The remaining authors declared no competing interests.

Figures

Figure 1
Figure 1. Performance of estimating equations by clinical subgroups
Panel a: Bias:Median difference between measured and estimated GFR; Panel b: Accuracy: Percentage of estimates greater than 30% of measured GFR (1-P30). eGFRcr, estimated GFR by the CKD-EPI equation; eGFRcys, estimated GFR by the CKD-EPI cystatin C equation; eGFRcr-cys, estimated GFR by the CKD-EPI creatinine-cystatin C equation. The number of participants in each subgroup are age ≤50 (132), > 50 (68); female (55), male (145); Blacks (104), non Blacks (96); body mass index (kg/m2) <22 (35), 22–30 (129), >30 (36); diabetes yes (16), no (184).
Figure 2
Figure 2. Performance of estimating equations by tenofovir, CD4 and viral load subgroups
Panel a: Bias: Median difference between measured and estimated GFR; Panel b: Accuracy: Percentage of estimates greater than 30% of measured GFR (1-P30) The number of participants in each subgroup are tenofovir status yes (125), no (75); CD4 count (cells/ul) <350 (56), ≥ 350 (144); Viral load (copies/mL) <1000 or undetected (168), ≥ 1000 (14); serum albumin (mg/dl) <3.6 (43), ≥ 3.6 (157); serum C- reactive protein (mg/L) <4.8 (150), ≥ 4.8 (50).
See this image and copyright information in PMC

References

    1. Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet. 1998 Nov 28;352(9142):1725–1730. - PubMed
    1. Palella FJ, Jr, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006 Sep;43(1):27–34. - PubMed
    1. Palella FJ, Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998 Mar 26;338(13):853–860. - PubMed
    1. Vittinghoff E, Scheer S, O’Malley P, Colfax G, Holmberg SD, Buchbinder SP. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. The Journal of infectious diseases. 1999 Mar;179(3):717–720. - PubMed
    1. Seaberg EC, Munoz A, Lu M, et al. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS. 2005 Jun 10;19(9):953–960. - PubMed

Publication types